Global Prostrate Cancer Diagnostics Market By Type (Screening Tests (Digital rectal exam (DRE), Prostate-specific antigen (PSA) test), Confirmatory Tests (PCA3Test, Transrectal Ultrasound, Prostate Biopsy, MRI Fusion), Blood-based assay, Others); By Cancer Types (Acinar Adenocarcinoma, Ductal Adenocarcinoma, Transitional Cell (Or Urothelial) Cancer, Squamous Cell Cancer, Small Cell Prostate Cancer); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway),Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027